ArticleOncology reports2015

HOXD10 acts as a tumor-suppressive factor via inhibition of the RHOC/AKT/MAPK pathway in human cholangiocellular carcinoma.

Haixia Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.